Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides.
D000818:Animals; D001391:Azo Compounds / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002645:Chickens; D004285:Dogs; D005703:Gallamine Triethiodide / Q000494:pharmacology; D000882:Haplorhini; D007093:Imidazoles / Q000378:metabolism / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009467:Neuromuscular Depolarizing Agents / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D010197:Pancuronium / Q000494:pharmacology; D011726:Pyridinium Compounds / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D001391:Azo Compounds; D007093:Imidazoles; D009467:Neuromuscular Depolarizing Agents; D011726:Pyridinium Compounds; D013390:Succinylcholine; D010197:Pancuronium; D005703:Gallamine Triethiodide; D014403:Tubocurarine